{
    "nct_id": "NCT04407754",
    "official_title": "Myo-Inositol as an Adjuvant to Letrozole for Infertility in PolyCystic Ovary Syndrome (MALI-PCOS): a Randomized Pilot Trial",
    "inclusion_criteria": "* Female patient age 18-36\n* Desire for pregnancy\n* Diagnosis of oligo- or anovulation secondary to polycystic ovary syndrome -All subjects must have ovulatory dysfunction and at least one of the remaining two criteria:hyperandrogenism or polycystic ovarian morphology on ultrasound\n* At least one patent fallopian tube\n* Normal uterine cavity\n* Male partner with sperm concentration of at least 14 million/mL in at least one ejaculate.\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 36 Years",
    "exclusion_criteria": "* Cause of anovulation other than PCOS such as uncontrolled thyroid dysfunction or hyperprolactinemia\n* Presence of another major infertility factor\n* Diabetes\n* Contraindication to pregnancy\n* Myo-inositol use < 3 months prior to study enrollment\n* Concomitant metformin use. Previous use is allowed with last use at least 6 weeks prior to randomization.",
    "miscellaneous_criteria": ""
}